CI
DGX icon

Cigna Investments’s Quest Diagnostics DGX Stock Holding History

Cigna Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Sell
1,068
-37
-3% -$7.26K 0.03% 439
2026
Q1 		$217K Buy
+1,105
New +$215K 0.03% 422
2025
Q4 		– Sell
-1,105
Closed -$211K – 466
2025
Q3 		$211K Buy
+1,105
New +$196K 0.03% 448
2023
Q1 		– Sell
-1,441
Closed -$225K – 457
2022
Q4 		$225K Buy
+1,441
New +$207K 0.05% 400
2022
Q3 		– Sell
-1,522
Closed -$203K – 440
2022
Q2 		$203K Sell
1,522
-595
-28% -$81.1K 0.04% 437
2022
Q1 		$290K Sell
2,117
-688
-25% -$95.9K 0.04% 457
2021
Q4 		$485K Sell
2,805
-1,082
-28% -$165K 0.04% 380
2021
Q3 		$564K Sell
3,887
-147
-4% -$21.5K 0.04% 395
2021
Q2 		$532K Sell
4,034
-786
-16% -$103K 0.04% 418
2021
Q1 		$618K Buy
4,820
+172
+4% +$21.2K 0.04% 392
2020
Q4 		$554K Buy
4,648
+365
+9% +$44.5K 0.04% 378
2020
Q3 		$491K Hold
4,283
– – 0.05% 346
2020
Q2 		$487K Buy
4,283
+456
+12% +$48.4K 0.05% 393
2020
Q1 		$307K Buy
3,827
+250
+7% +$25.9K 0.04% 444
2019
Q4 		$396K Sell
3,577
-361
-9% -$37.6K 0.04% 439
2019
Q3 		$399K Buy
3,938
+200
+5% +$20.5K 0.04% 454
2019
Q2 		$381K Sell
3,738
-200
-5% -$19.2K 0.04% 457
2019
Q1 		$354K Sell
3,938
-100
-2% -$8.66K 0.04% 479
2018
Q4 		$337K Buy
4,038
+40
+1% +$3.75K 0.03% 475
2018
Q3 		$377K Sell
3,998
-400
-9% -$43.9K 0.03% 456
2018
Q2 		$484K Sell
4,398
-626
-12% -$65.2K 0.04% 429
2018
Q1 		$504K Sell
5,024
-62
-1% -$6.35K 0.03% 454
2017
Q4 		$500K Sell
5,086
-200
-4% -$19K 0.03% 476
2017
Q3 		$495K Sell
5,286
-16
-0.3% -$1.7K 0.03% 461
2017
Q2 		$589K Sell
5,302
-495
-9% -$52.3K 0.04% 390
2017
Q1 		$569K Buy
5,797
+685
+13% +$65.3K 0.04% 405
2016
Q4 		$470K Buy
+5,112
New +$441K 0.05% 425

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Cigna Investments's DGX Position: Q2 2026 in Review

Cigna Investments reduced its Quest Diagnostics (DGX) stake by 3.3% in Q2 2026, selling an estimated $7.26K and leaving 1,068 shares worth $226K. The position accounts for 0.03% of the portfolio, ranked #439.

Cigna Investments first reported a position in DGX in Q4 2016 and has held it in 27 quarters since. The position peaked at $618K in Q1 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Cigna Investments held 1,068 shares of Quest Diagnostics worth $226K as of Q2 2026.
  • Cigna Investments sold 37 Quest Diagnostics shares in Q2 2026, an estimated $7.26K.
  • Quest Diagnostics made up 0.03% of Cigna Investments's portfolio in Q2 2026, its #439 holding.
  • Cigna Investments first reported a position in Quest Diagnostics in Q4 2016 and has held it in 27 quarters since.
  • Cigna Investments's Quest Diagnostics position peaked at $618K in Q1 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.